Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2012 1
2014 3
2015 5
2016 8
2017 8
2018 6
2019 9
2020 18
2021 14
Text availability
Article attribute
Article type
Publication date

Search Results

66 results
Results by year
Filters applied: . Clear all
Page 1
Assessment of Outcomes After Stopping Tyrosine Kinase Inhibitors Among Patients With Chronic Myeloid Leukemia: A Nonrandomized Clinical Trial.
Atallah E, Schiffer CA, Radich JP, Weinfurt KP, Zhang MJ, Pinilla-Ibarz J, Kota V, Larson RA, Moore JO, Mauro MJ, Deininger MWN, Thompson JE, Oehler VG, Wadleigh M, Shah NP, Ritchie EK, Silver RT, Cortes J, Lin L, Visotcky A, Baim A, Harrell J, Helton B, Horowitz M, Flynn KE. Atallah E, et al. Among authors: kota v. JAMA Oncol. 2021 Jan 1;7(1):42-50. doi: 10.1001/jamaoncol.2020.5774. JAMA Oncol. 2021. PMID: 33180106 Free PMC article.
Mortality trends in sickle cell patients.
Cintron-Garcia J, Ajebo G, Kota V, Guddati AK. Cintron-Garcia J, et al. Among authors: kota v. Am J Blood Res. 2020 Oct 15;10(5):190-197. eCollection 2020. Am J Blood Res. 2020. PMID: 33224563 Free PMC article.
Role of indoleamine 2,3-dioxygenase in acute myeloid leukemia.
Sobash PT, Kolhe R, Karim NA, Guddati AK, Jillella A, Kota V. Sobash PT, et al. Among authors: kota v. Future Oncol. 2020 Dec;16(36):3085-3094. doi: 10.2217/fon-2019-0642. Epub 2020 Sep 25. Future Oncol. 2020. PMID: 32976029 Review.
Volasertib for AML: clinical use and patient consideration.
Hao Z, Kota V. Hao Z, et al. Among authors: kota v. Onco Targets Ther. 2015 Jul 17;8:1761-71. doi: 10.2147/OTT.S60762. eCollection 2015. Onco Targets Ther. 2015. PMID: 26229484 Free PMC article. Review.
66 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page